Global Major Depressive Disorder Drug Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Major Depressive Disorder Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Major Depressive Disorder Drug Industry Forecast” looks at past sales and reviews total world Major Depressive Disorder Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Major Depressive Disorder Drug sales for 2025 through 2031. With Major Depressive Disorder Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Major Depressive Disorder Drug industry.
This Insight Report provides a comprehensive analysis of the global Major Depressive Disorder Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Major Depressive Disorder Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Major Depressive Disorder Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Major Depressive Disorder Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Major Depressive Disorder Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Major Depressive Disorder Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Major Depressive Disorder Drug market?
What factors are driving Major Depressive Disorder Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Major Depressive Disorder Drug market opportunities vary by end market size?
How does Major Depressive Disorder Drug break out by Type, by Application?
The global Major Depressive Disorder Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Major Depressive Disorder Drug Industry Forecast” looks at past sales and reviews total world Major Depressive Disorder Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Major Depressive Disorder Drug sales for 2025 through 2031. With Major Depressive Disorder Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Major Depressive Disorder Drug industry.
This Insight Report provides a comprehensive analysis of the global Major Depressive Disorder Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Major Depressive Disorder Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Major Depressive Disorder Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Major Depressive Disorder Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Major Depressive Disorder Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Major Depressive Disorder Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Aripiprazole
- AV-101
- AVP-786
- Basimglurant
- Brexpiprazole
- Others
- Hospital
- Clinic
- Research Center
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bristol-Myers Squibb Company
- Cerecor Inc.
- e-Therapeutics Plc
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- H. Lundbeck A/S
- Hua Medicine Ltd.
- Intra-Cellular Therapies, Inc.
What is the 10-year outlook for the global Major Depressive Disorder Drug market?
What factors are driving Major Depressive Disorder Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Major Depressive Disorder Drug market opportunities vary by end market size?
How does Major Depressive Disorder Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Major Depressive Disorder Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Major Depressive Disorder Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Major Depressive Disorder Drug by Country/Region, 2020, 2024 & 2031
2.2 Major Depressive Disorder Drug Segment by Type
2.2.1 Aripiprazole
2.2.2 AV-101
2.2.3 AVP-786
2.2.4 Basimglurant
2.2.5 Brexpiprazole
2.2.6 Others
2.3 Major Depressive Disorder Drug Sales by Type
2.3.1 Global Major Depressive Disorder Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Major Depressive Disorder Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Major Depressive Disorder Drug Sale Price by Type (2020-2025)
2.4 Major Depressive Disorder Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Research Center
2.5 Major Depressive Disorder Drug Sales by Application
2.5.1 Global Major Depressive Disorder Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Major Depressive Disorder Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Major Depressive Disorder Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Major Depressive Disorder Drug Breakdown Data by Company
3.1.1 Global Major Depressive Disorder Drug Annual Sales by Company (2020-2025)
3.1.2 Global Major Depressive Disorder Drug Sales Market Share by Company (2020-2025)
3.2 Global Major Depressive Disorder Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Major Depressive Disorder Drug Revenue by Company (2020-2025)
3.2.2 Global Major Depressive Disorder Drug Revenue Market Share by Company (2020-2025)
3.3 Global Major Depressive Disorder Drug Sale Price by Company
3.4 Key Manufacturers Major Depressive Disorder Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Major Depressive Disorder Drug Product Location Distribution
3.4.2 Players Major Depressive Disorder Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MAJOR DEPRESSIVE DISORDER DRUG BY GEOGRAPHIC REGION
4.1 World Historic Major Depressive Disorder Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Major Depressive Disorder Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Major Depressive Disorder Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Major Depressive Disorder Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Major Depressive Disorder Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Major Depressive Disorder Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Major Depressive Disorder Drug Sales Growth
4.4 APAC Major Depressive Disorder Drug Sales Growth
4.5 Europe Major Depressive Disorder Drug Sales Growth
4.6 Middle East & Africa Major Depressive Disorder Drug Sales Growth
5 AMERICAS
5.1 Americas Major Depressive Disorder Drug Sales by Country
5.1.1 Americas Major Depressive Disorder Drug Sales by Country (2020-2025)
5.1.2 Americas Major Depressive Disorder Drug Revenue by Country (2020-2025)
5.2 Americas Major Depressive Disorder Drug Sales by Type (2020-2025)
5.3 Americas Major Depressive Disorder Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Major Depressive Disorder Drug Sales by Region
6.1.1 APAC Major Depressive Disorder Drug Sales by Region (2020-2025)
6.1.2 APAC Major Depressive Disorder Drug Revenue by Region (2020-2025)
6.2 APAC Major Depressive Disorder Drug Sales by Type (2020-2025)
6.3 APAC Major Depressive Disorder Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Major Depressive Disorder Drug by Country
7.1.1 Europe Major Depressive Disorder Drug Sales by Country (2020-2025)
7.1.2 Europe Major Depressive Disorder Drug Revenue by Country (2020-2025)
7.2 Europe Major Depressive Disorder Drug Sales by Type (2020-2025)
7.3 Europe Major Depressive Disorder Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Major Depressive Disorder Drug by Country
8.1.1 Middle East & Africa Major Depressive Disorder Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Major Depressive Disorder Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Major Depressive Disorder Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Major Depressive Disorder Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Major Depressive Disorder Drug
10.3 Manufacturing Process Analysis of Major Depressive Disorder Drug
10.4 Industry Chain Structure of Major Depressive Disorder Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Major Depressive Disorder Drug Distributors
11.3 Major Depressive Disorder Drug Customer
12 WORLD FORECAST REVIEW FOR MAJOR DEPRESSIVE DISORDER DRUG BY GEOGRAPHIC REGION
12.1 Global Major Depressive Disorder Drug Market Size Forecast by Region
12.1.1 Global Major Depressive Disorder Drug Forecast by Region (2026-2031)
12.1.2 Global Major Depressive Disorder Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Major Depressive Disorder Drug Forecast by Type (2026-2031)
12.7 Global Major Depressive Disorder Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bristol-Myers Squibb Company
13.1.1 Bristol-Myers Squibb Company Company Information
13.1.2 Bristol-Myers Squibb Company Major Depressive Disorder Drug Product Portfolios and Specifications
13.1.3 Bristol-Myers Squibb Company Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bristol-Myers Squibb Company Main Business Overview
13.1.5 Bristol-Myers Squibb Company Latest Developments
13.2 Cerecor Inc.
13.2.1 Cerecor Inc. Company Information
13.2.2 Cerecor Inc. Major Depressive Disorder Drug Product Portfolios and Specifications
13.2.3 Cerecor Inc. Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Cerecor Inc. Main Business Overview
13.2.5 Cerecor Inc. Latest Developments
13.3 e-Therapeutics Plc
13.3.1 e-Therapeutics Plc Company Information
13.3.2 e-Therapeutics Plc Major Depressive Disorder Drug Product Portfolios and Specifications
13.3.3 e-Therapeutics Plc Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 e-Therapeutics Plc Main Business Overview
13.3.5 e-Therapeutics Plc Latest Developments
13.4 Eli Lilly and Company
13.4.1 Eli Lilly and Company Company Information
13.4.2 Eli Lilly and Company Major Depressive Disorder Drug Product Portfolios and Specifications
13.4.3 Eli Lilly and Company Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Eli Lilly and Company Main Business Overview
13.4.5 Eli Lilly and Company Latest Developments
13.5 F. Hoffmann-La Roche Ltd.
13.5.1 F. Hoffmann-La Roche Ltd. Company Information
13.5.2 F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Product Portfolios and Specifications
13.5.3 F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 F. Hoffmann-La Roche Ltd. Main Business Overview
13.5.5 F. Hoffmann-La Roche Ltd. Latest Developments
13.6 GlaxoSmithKline Plc
13.6.1 GlaxoSmithKline Plc Company Information
13.6.2 GlaxoSmithKline Plc Major Depressive Disorder Drug Product Portfolios and Specifications
13.6.3 GlaxoSmithKline Plc Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 GlaxoSmithKline Plc Main Business Overview
13.6.5 GlaxoSmithKline Plc Latest Developments
13.7 H. Lundbeck A/S
13.7.1 H. Lundbeck A/S Company Information
13.7.2 H. Lundbeck A/S Major Depressive Disorder Drug Product Portfolios and Specifications
13.7.3 H. Lundbeck A/S Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 H. Lundbeck A/S Main Business Overview
13.7.5 H. Lundbeck A/S Latest Developments
13.8 Hua Medicine Ltd.
13.8.1 Hua Medicine Ltd. Company Information
13.8.2 Hua Medicine Ltd. Major Depressive Disorder Drug Product Portfolios and Specifications
13.8.3 Hua Medicine Ltd. Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Hua Medicine Ltd. Main Business Overview
13.8.5 Hua Medicine Ltd. Latest Developments
13.9 Intra-Cellular Therapies, Inc.
13.9.1 Intra-Cellular Therapies, Inc. Company Information
13.9.2 Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Product Portfolios and Specifications
13.9.3 Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Intra-Cellular Therapies, Inc. Main Business Overview
13.9.5 Intra-Cellular Therapies, Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Major Depressive Disorder Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Major Depressive Disorder Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Aripiprazole
Table 4. Major Players of AV-101
Table 5. Major Players of AVP-786
Table 6. Major Players of Basimglurant
Table 7. Major Players of Brexpiprazole
Table 8. Major Players of Others
Table 9. Global Major Depressive Disorder Drug Sales byType (2020-2025) & (K Pcs)
Table 10. Global Major Depressive Disorder Drug Sales Market Share byType (2020-2025)
Table 11. Global Major Depressive Disorder Drug Revenue byType (2020-2025) & ($ million)
Table 12. Global Major Depressive Disorder Drug Revenue Market Share byType (2020-2025)
Table 13. Global Major Depressive Disorder Drug Sale Price byType (2020-2025) & (USD/Pcs)
Table 14. Global Major Depressive Disorder Drug Sale by Application (2020-2025) & (K Pcs)
Table 15. Global Major Depressive Disorder Drug Sale Market Share by Application (2020-2025)
Table 16. Global Major Depressive Disorder Drug Revenue by Application (2020-2025) & ($ million)
Table 17. Global Major Depressive Disorder Drug Revenue Market Share by Application (2020-2025)
Table 18. Global Major Depressive Disorder Drug Sale Price by Application (2020-2025) & (USD/Pcs)
Table 19. Global Major Depressive Disorder Drug Sales by Company (2020-2025) & (K Pcs)
Table 20. Global Major Depressive Disorder Drug Sales Market Share by Company (2020-2025)
Table 21. Global Major Depressive Disorder Drug Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Major Depressive Disorder Drug Revenue Market Share by Company (2020-2025)
Table 23. Global Major Depressive Disorder Drug Sale Price by Company (2020-2025) & (USD/Pcs)
Table 24. Key Manufacturers Major Depressive Disorder Drug Producing Area Distribution and Sales Area
Table 25. Players Major Depressive Disorder Drug Products Offered
Table 26. Major Depressive Disorder Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Major Depressive Disorder Drug Sales by Geographic Region (2020-2025) & (K Pcs)
Table 30. Global Major Depressive Disorder Drug Sales Market Share Geographic Region (2020-2025)
Table 31. Global Major Depressive Disorder Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Major Depressive Disorder Drug Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Major Depressive Disorder Drug Sales by Country/Region (2020-2025) & (K Pcs)
Table 34. Global Major Depressive Disorder Drug Sales Market Share by Country/Region (2020-2025)
Table 35. Global Major Depressive Disorder Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Major Depressive Disorder Drug Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Major Depressive Disorder Drug Sales by Country (2020-2025) & (K Pcs)
Table 38. Americas Major Depressive Disorder Drug Sales Market Share by Country (2020-2025)
Table 39. Americas Major Depressive Disorder Drug Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Major Depressive Disorder Drug Sales byType (2020-2025) & (K Pcs)
Table 41. Americas Major Depressive Disorder Drug Sales by Application (2020-2025) & (K Pcs)
Table 42. APAC Major Depressive Disorder Drug Sales by Region (2020-2025) & (K Pcs)
Table 43. APAC Major Depressive Disorder Drug Sales Market Share by Region (2020-2025)
Table 44. APAC Major Depressive Disorder Drug Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Major Depressive Disorder Drug Sales byType (2020-2025) & (K Pcs)
Table 46. APAC Major Depressive Disorder Drug Sales by Application (2020-2025) & (K Pcs)
Table 47. Europe Major Depressive Disorder Drug Sales by Country (2020-2025) & (K Pcs)
Table 48. Europe Major Depressive Disorder Drug Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Major Depressive Disorder Drug Sales byType (2020-2025) & (K Pcs)
Table 50. Europe Major Depressive Disorder Drug Sales by Application (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Major Depressive Disorder Drug Sales by Country (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Major Depressive Disorder Drug Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Major Depressive Disorder Drug Sales byType (2020-2025) & (K Pcs)
Table 54. Middle East & Africa Major Depressive Disorder Drug Sales by Application (2020-2025) & (K Pcs)
Table 55. Key Market Drivers & Growth Opportunities of Major Depressive Disorder Drug
Table 56. Key Market Challenges & Risks of Major Depressive Disorder Drug
Table 57. Key IndustryTrends of Major Depressive Disorder Drug
Table 58. Major Depressive Disorder Drug Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Major Depressive Disorder Drug Distributors List
Table 61. Major Depressive Disorder Drug Customer List
Table 62. Global Major Depressive Disorder Drug SalesForecast by Region (2026-2031) & (K Pcs)
Table 63. Global Major Depressive Disorder Drug RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Americas Major Depressive Disorder Drug SalesForecast by Country (2026-2031) & (K Pcs)
Table 65. Americas Major Depressive Disorder Drug Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. APAC Major Depressive Disorder Drug SalesForecast by Region (2026-2031) & (K Pcs)
Table 67. APAC Major Depressive Disorder Drug Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 68. Europe Major Depressive Disorder Drug SalesForecast by Country (2026-2031) & (K Pcs)
Table 69. Europe Major Depressive Disorder Drug RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Major Depressive Disorder Drug SalesForecast by Country (2026-2031) & (K Pcs)
Table 71. Middle East & Africa Major Depressive Disorder Drug RevenueForecast by Country (2026-2031) & ($ millions)
Table 72. Global Major Depressive Disorder Drug SalesForecast byType (2026-2031) & (K Pcs)
Table 73. Global Major Depressive Disorder Drug RevenueForecast byType (2026-2031) & ($ millions)
Table 74. Global Major Depressive Disorder Drug SalesForecast by Application (2026-2031) & (K Pcs)
Table 75. Global Major Depressive Disorder Drug RevenueForecast by Application (2026-2031) & ($ millions)
Table 76. Bristol-Myers Squibb Company Basic Information, Major Depressive Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 77. Bristol-Myers Squibb Company Major Depressive Disorder Drug Product Portfolios and Specifications
Table 78. Bristol-Myers Squibb Company Major Depressive Disorder Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 79. Bristol-Myers Squibb Company Main Business
Table 80. Bristol-Myers Squibb Company Latest Developments
Table 81. Cerecor Inc. Basic Information, Major Depressive Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. Cerecor Inc. Major Depressive Disorder Drug Product Portfolios and Specifications
Table 83. Cerecor Inc. Major Depressive Disorder Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 84. Cerecor Inc. Main Business
Table 85. Cerecor Inc. Latest Developments
Table 86. e-Therapeutics Plc Basic Information, Major Depressive Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. e-Therapeutics Plc Major Depressive Disorder Drug Product Portfolios and Specifications
Table 88. e-Therapeutics Plc Major Depressive Disorder Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 89. e-Therapeutics Plc Main Business
Table 90. e-Therapeutics Plc Latest Developments
Table 91. Eli Lilly and Company Basic Information, Major Depressive Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. Eli Lilly and Company Major Depressive Disorder Drug Product Portfolios and Specifications
Table 93. Eli Lilly and Company Major Depressive Disorder Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 94. Eli Lilly and Company Main Business
Table 95. Eli Lilly and Company Latest Developments
Table 96.F. Hoffmann-La Roche Ltd. Basic Information, Major Depressive Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 97.F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Product Portfolios and Specifications
Table 98.F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 99.F. Hoffmann-La Roche Ltd. Main Business
Table 100.F. Hoffmann-La Roche Ltd. Latest Developments
Table 101. GlaxoSmithKline Plc Basic Information, Major Depressive Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. GlaxoSmithKline Plc Major Depressive Disorder Drug Product Portfolios and Specifications
Table 103. GlaxoSmithKline Plc Major Depressive Disorder Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 104. GlaxoSmithKline Plc Main Business
Table 105. GlaxoSmithKline Plc Latest Developments
Table 106. H. Lundbeck A/S Basic Information, Major Depressive Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. H. Lundbeck A/S Major Depressive Disorder Drug Product Portfolios and Specifications
Table 108. H. Lundbeck A/S Major Depressive Disorder Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 109. H. Lundbeck A/S Main Business
Table 110. H. Lundbeck A/S Latest Developments
Table 111. Hua Medicine Ltd. Basic Information, Major Depressive Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Hua Medicine Ltd. Major Depressive Disorder Drug Product Portfolios and Specifications
Table 113. Hua Medicine Ltd. Major Depressive Disorder Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 114. Hua Medicine Ltd. Main Business
Table 115. Hua Medicine Ltd. Latest Developments
Table 116. Intra-CellularTherapies, Inc. Basic Information, Major Depressive Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Intra-CellularTherapies, Inc. Major Depressive Disorder Drug Product Portfolios and Specifications
Table 118. Intra-CellularTherapies, Inc. Major Depressive Disorder Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 119. Intra-CellularTherapies, Inc. Main Business
Table 120. Intra-CellularTherapies, Inc. Latest Developments
LIST OFFIGURES
Figure 1. Picture of Major Depressive Disorder Drug
Figure 2. Major Depressive Disorder Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Major Depressive Disorder Drug Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Major Depressive Disorder Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Major Depressive Disorder Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Major Depressive Disorder Drug Sales Market Share by Country/Region (2024)
Figure 10. Major Depressive Disorder Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Aripiprazole
Figure 12. Product Picture of AV-101
Figure 13. Product Picture of AVP-786
Figure 14. Product Picture of Basimglurant
Figure 15. Product Picture of Brexpiprazole
Figure 16. Product Picture of Others
Figure 17. Global Major Depressive Disorder Drug Sales Market Share byType in 2025
Figure 18. Global Major Depressive Disorder Drug Revenue Market Share byType (2020-2025)
Figure 19. Major Depressive Disorder Drug Consumed in Hospital
Figure 20. Global Major Depressive Disorder Drug Market: Hospital (2020-2025) & (K Pcs)
Figure 21. Major Depressive Disorder Drug Consumed in Clinic
Figure 22. Global Major Depressive Disorder Drug Market: Clinic (2020-2025) & (K Pcs)
Figure 23. Major Depressive Disorder Drug Consumed in Research Center
Figure 24. Global Major Depressive Disorder Drug Market: Research Center (2020-2025) & (K Pcs)
Figure 25. Global Major Depressive Disorder Drug Sale Market Share by Application (2024)
Figure 26. Global Major Depressive Disorder Drug Revenue Market Share by Application in 2025
Figure 27. Major Depressive Disorder Drug Sales by Company in 2025 (K Pcs)
Figure 28. Global Major Depressive Disorder Drug Sales Market Share by Company in 2025
Figure 29. Major Depressive Disorder Drug Revenue by Company in 2025 ($ millions)
Figure 30. Global Major Depressive Disorder Drug Revenue Market Share by Company in 2025
Figure 31. Global Major Depressive Disorder Drug Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Major Depressive Disorder Drug Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Major Depressive Disorder Drug Sales 2020-2025 (K Pcs)
Figure 34. Americas Major Depressive Disorder Drug Revenue 2020-2025 ($ millions)
Figure 35. APAC Major Depressive Disorder Drug Sales 2020-2025 (K Pcs)
Figure 36. APAC Major Depressive Disorder Drug Revenue 2020-2025 ($ millions)
Figure 37. Europe Major Depressive Disorder Drug Sales 2020-2025 (K Pcs)
Figure 38. Europe Major Depressive Disorder Drug Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Major Depressive Disorder Drug Sales 2020-2025 (K Pcs)
Figure 40. Middle East & Africa Major Depressive Disorder Drug Revenue 2020-2025 ($ millions)
Figure 41. Americas Major Depressive Disorder Drug Sales Market Share by Country in 2025
Figure 42. Americas Major Depressive Disorder Drug Revenue Market Share by Country (2020-2025)
Figure 43. Americas Major Depressive Disorder Drug Sales Market Share byType (2020-2025)
Figure 44. Americas Major Depressive Disorder Drug Sales Market Share by Application (2020-2025)
Figure 45. United States Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Major Depressive Disorder Drug Sales Market Share by Region in 2025
Figure 50. APAC Major Depressive Disorder Drug Revenue Market Share by Region (2020-2025)
Figure 51. APAC Major Depressive Disorder Drug Sales Market Share byType (2020-2025)
Figure 52. APAC Major Depressive Disorder Drug Sales Market Share by Application (2020-2025)
Figure 53. China Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. India Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 59. ChinaTaiwan Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Major Depressive Disorder Drug Sales Market Share by Country in 2025
Figure 61. Europe Major Depressive Disorder Drug Revenue Market Share by Country (2020-2025)
Figure 62. Europe Major Depressive Disorder Drug Sales Market Share byType (2020-2025)
Figure 63. Europe Major Depressive Disorder Drug Sales Market Share by Application (2020-2025)
Figure 64. Germany Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 65.France Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Major Depressive Disorder Drug Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Major Depressive Disorder Drug Sales Market Share byType (2020-2025)
Figure 71. Middle East & Africa Major Depressive Disorder Drug Sales Market Share by Application (2020-2025)
Figure 72. Egypt Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 75.Turkey Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Major Depressive Disorder Drug in 2025
Figure 78. Manufacturing Process Analysis of Major Depressive Disorder Drug
Figure 79. Industry Chain Structure of Major Depressive Disorder Drug
Figure 80. Channels of Distribution
Figure 81. Global Major Depressive Disorder Drug Sales MarketForecast by Region (2026-2031)
Figure 82. Global Major Depressive Disorder Drug Revenue Market ShareForecast by Region (2026-2031)
Figure 83. Global Major Depressive Disorder Drug Sales Market ShareForecast byType (2026-2031)
Figure 84. Global Major Depressive Disorder Drug Revenue Market ShareForecast byType (2026-2031)
Figure 85. Global Major Depressive Disorder Drug Sales Market ShareForecast by Application (2026-2031)
Figure 86. Global Major Depressive Disorder Drug Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Major Depressive Disorder Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Major Depressive Disorder Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Major Depressive Disorder Drug by Country/Region, 2020, 2024 & 2031
2.2 Major Depressive Disorder Drug Segment by Type
2.2.1 Aripiprazole
2.2.2 AV-101
2.2.3 AVP-786
2.2.4 Basimglurant
2.2.5 Brexpiprazole
2.2.6 Others
2.3 Major Depressive Disorder Drug Sales by Type
2.3.1 Global Major Depressive Disorder Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Major Depressive Disorder Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Major Depressive Disorder Drug Sale Price by Type (2020-2025)
2.4 Major Depressive Disorder Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Research Center
2.5 Major Depressive Disorder Drug Sales by Application
2.5.1 Global Major Depressive Disorder Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Major Depressive Disorder Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Major Depressive Disorder Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Major Depressive Disorder Drug Breakdown Data by Company
3.1.1 Global Major Depressive Disorder Drug Annual Sales by Company (2020-2025)
3.1.2 Global Major Depressive Disorder Drug Sales Market Share by Company (2020-2025)
3.2 Global Major Depressive Disorder Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Major Depressive Disorder Drug Revenue by Company (2020-2025)
3.2.2 Global Major Depressive Disorder Drug Revenue Market Share by Company (2020-2025)
3.3 Global Major Depressive Disorder Drug Sale Price by Company
3.4 Key Manufacturers Major Depressive Disorder Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Major Depressive Disorder Drug Product Location Distribution
3.4.2 Players Major Depressive Disorder Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MAJOR DEPRESSIVE DISORDER DRUG BY GEOGRAPHIC REGION
4.1 World Historic Major Depressive Disorder Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Major Depressive Disorder Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Major Depressive Disorder Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Major Depressive Disorder Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Major Depressive Disorder Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Major Depressive Disorder Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Major Depressive Disorder Drug Sales Growth
4.4 APAC Major Depressive Disorder Drug Sales Growth
4.5 Europe Major Depressive Disorder Drug Sales Growth
4.6 Middle East & Africa Major Depressive Disorder Drug Sales Growth
5 AMERICAS
5.1 Americas Major Depressive Disorder Drug Sales by Country
5.1.1 Americas Major Depressive Disorder Drug Sales by Country (2020-2025)
5.1.2 Americas Major Depressive Disorder Drug Revenue by Country (2020-2025)
5.2 Americas Major Depressive Disorder Drug Sales by Type (2020-2025)
5.3 Americas Major Depressive Disorder Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Major Depressive Disorder Drug Sales by Region
6.1.1 APAC Major Depressive Disorder Drug Sales by Region (2020-2025)
6.1.2 APAC Major Depressive Disorder Drug Revenue by Region (2020-2025)
6.2 APAC Major Depressive Disorder Drug Sales by Type (2020-2025)
6.3 APAC Major Depressive Disorder Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Major Depressive Disorder Drug by Country
7.1.1 Europe Major Depressive Disorder Drug Sales by Country (2020-2025)
7.1.2 Europe Major Depressive Disorder Drug Revenue by Country (2020-2025)
7.2 Europe Major Depressive Disorder Drug Sales by Type (2020-2025)
7.3 Europe Major Depressive Disorder Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Major Depressive Disorder Drug by Country
8.1.1 Middle East & Africa Major Depressive Disorder Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Major Depressive Disorder Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Major Depressive Disorder Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Major Depressive Disorder Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Major Depressive Disorder Drug
10.3 Manufacturing Process Analysis of Major Depressive Disorder Drug
10.4 Industry Chain Structure of Major Depressive Disorder Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Major Depressive Disorder Drug Distributors
11.3 Major Depressive Disorder Drug Customer
12 WORLD FORECAST REVIEW FOR MAJOR DEPRESSIVE DISORDER DRUG BY GEOGRAPHIC REGION
12.1 Global Major Depressive Disorder Drug Market Size Forecast by Region
12.1.1 Global Major Depressive Disorder Drug Forecast by Region (2026-2031)
12.1.2 Global Major Depressive Disorder Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Major Depressive Disorder Drug Forecast by Type (2026-2031)
12.7 Global Major Depressive Disorder Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bristol-Myers Squibb Company
13.1.1 Bristol-Myers Squibb Company Company Information
13.1.2 Bristol-Myers Squibb Company Major Depressive Disorder Drug Product Portfolios and Specifications
13.1.3 Bristol-Myers Squibb Company Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bristol-Myers Squibb Company Main Business Overview
13.1.5 Bristol-Myers Squibb Company Latest Developments
13.2 Cerecor Inc.
13.2.1 Cerecor Inc. Company Information
13.2.2 Cerecor Inc. Major Depressive Disorder Drug Product Portfolios and Specifications
13.2.3 Cerecor Inc. Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Cerecor Inc. Main Business Overview
13.2.5 Cerecor Inc. Latest Developments
13.3 e-Therapeutics Plc
13.3.1 e-Therapeutics Plc Company Information
13.3.2 e-Therapeutics Plc Major Depressive Disorder Drug Product Portfolios and Specifications
13.3.3 e-Therapeutics Plc Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 e-Therapeutics Plc Main Business Overview
13.3.5 e-Therapeutics Plc Latest Developments
13.4 Eli Lilly and Company
13.4.1 Eli Lilly and Company Company Information
13.4.2 Eli Lilly and Company Major Depressive Disorder Drug Product Portfolios and Specifications
13.4.3 Eli Lilly and Company Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Eli Lilly and Company Main Business Overview
13.4.5 Eli Lilly and Company Latest Developments
13.5 F. Hoffmann-La Roche Ltd.
13.5.1 F. Hoffmann-La Roche Ltd. Company Information
13.5.2 F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Product Portfolios and Specifications
13.5.3 F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 F. Hoffmann-La Roche Ltd. Main Business Overview
13.5.5 F. Hoffmann-La Roche Ltd. Latest Developments
13.6 GlaxoSmithKline Plc
13.6.1 GlaxoSmithKline Plc Company Information
13.6.2 GlaxoSmithKline Plc Major Depressive Disorder Drug Product Portfolios and Specifications
13.6.3 GlaxoSmithKline Plc Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 GlaxoSmithKline Plc Main Business Overview
13.6.5 GlaxoSmithKline Plc Latest Developments
13.7 H. Lundbeck A/S
13.7.1 H. Lundbeck A/S Company Information
13.7.2 H. Lundbeck A/S Major Depressive Disorder Drug Product Portfolios and Specifications
13.7.3 H. Lundbeck A/S Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 H. Lundbeck A/S Main Business Overview
13.7.5 H. Lundbeck A/S Latest Developments
13.8 Hua Medicine Ltd.
13.8.1 Hua Medicine Ltd. Company Information
13.8.2 Hua Medicine Ltd. Major Depressive Disorder Drug Product Portfolios and Specifications
13.8.3 Hua Medicine Ltd. Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Hua Medicine Ltd. Main Business Overview
13.8.5 Hua Medicine Ltd. Latest Developments
13.9 Intra-Cellular Therapies, Inc.
13.9.1 Intra-Cellular Therapies, Inc. Company Information
13.9.2 Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Product Portfolios and Specifications
13.9.3 Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Intra-Cellular Therapies, Inc. Main Business Overview
13.9.5 Intra-Cellular Therapies, Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Major Depressive Disorder Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Major Depressive Disorder Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Aripiprazole
Table 4. Major Players of AV-101
Table 5. Major Players of AVP-786
Table 6. Major Players of Basimglurant
Table 7. Major Players of Brexpiprazole
Table 8. Major Players of Others
Table 9. Global Major Depressive Disorder Drug Sales byType (2020-2025) & (K Pcs)
Table 10. Global Major Depressive Disorder Drug Sales Market Share byType (2020-2025)
Table 11. Global Major Depressive Disorder Drug Revenue byType (2020-2025) & ($ million)
Table 12. Global Major Depressive Disorder Drug Revenue Market Share byType (2020-2025)
Table 13. Global Major Depressive Disorder Drug Sale Price byType (2020-2025) & (USD/Pcs)
Table 14. Global Major Depressive Disorder Drug Sale by Application (2020-2025) & (K Pcs)
Table 15. Global Major Depressive Disorder Drug Sale Market Share by Application (2020-2025)
Table 16. Global Major Depressive Disorder Drug Revenue by Application (2020-2025) & ($ million)
Table 17. Global Major Depressive Disorder Drug Revenue Market Share by Application (2020-2025)
Table 18. Global Major Depressive Disorder Drug Sale Price by Application (2020-2025) & (USD/Pcs)
Table 19. Global Major Depressive Disorder Drug Sales by Company (2020-2025) & (K Pcs)
Table 20. Global Major Depressive Disorder Drug Sales Market Share by Company (2020-2025)
Table 21. Global Major Depressive Disorder Drug Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Major Depressive Disorder Drug Revenue Market Share by Company (2020-2025)
Table 23. Global Major Depressive Disorder Drug Sale Price by Company (2020-2025) & (USD/Pcs)
Table 24. Key Manufacturers Major Depressive Disorder Drug Producing Area Distribution and Sales Area
Table 25. Players Major Depressive Disorder Drug Products Offered
Table 26. Major Depressive Disorder Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Major Depressive Disorder Drug Sales by Geographic Region (2020-2025) & (K Pcs)
Table 30. Global Major Depressive Disorder Drug Sales Market Share Geographic Region (2020-2025)
Table 31. Global Major Depressive Disorder Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Major Depressive Disorder Drug Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Major Depressive Disorder Drug Sales by Country/Region (2020-2025) & (K Pcs)
Table 34. Global Major Depressive Disorder Drug Sales Market Share by Country/Region (2020-2025)
Table 35. Global Major Depressive Disorder Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Major Depressive Disorder Drug Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Major Depressive Disorder Drug Sales by Country (2020-2025) & (K Pcs)
Table 38. Americas Major Depressive Disorder Drug Sales Market Share by Country (2020-2025)
Table 39. Americas Major Depressive Disorder Drug Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Major Depressive Disorder Drug Sales byType (2020-2025) & (K Pcs)
Table 41. Americas Major Depressive Disorder Drug Sales by Application (2020-2025) & (K Pcs)
Table 42. APAC Major Depressive Disorder Drug Sales by Region (2020-2025) & (K Pcs)
Table 43. APAC Major Depressive Disorder Drug Sales Market Share by Region (2020-2025)
Table 44. APAC Major Depressive Disorder Drug Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Major Depressive Disorder Drug Sales byType (2020-2025) & (K Pcs)
Table 46. APAC Major Depressive Disorder Drug Sales by Application (2020-2025) & (K Pcs)
Table 47. Europe Major Depressive Disorder Drug Sales by Country (2020-2025) & (K Pcs)
Table 48. Europe Major Depressive Disorder Drug Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Major Depressive Disorder Drug Sales byType (2020-2025) & (K Pcs)
Table 50. Europe Major Depressive Disorder Drug Sales by Application (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Major Depressive Disorder Drug Sales by Country (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Major Depressive Disorder Drug Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Major Depressive Disorder Drug Sales byType (2020-2025) & (K Pcs)
Table 54. Middle East & Africa Major Depressive Disorder Drug Sales by Application (2020-2025) & (K Pcs)
Table 55. Key Market Drivers & Growth Opportunities of Major Depressive Disorder Drug
Table 56. Key Market Challenges & Risks of Major Depressive Disorder Drug
Table 57. Key IndustryTrends of Major Depressive Disorder Drug
Table 58. Major Depressive Disorder Drug Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Major Depressive Disorder Drug Distributors List
Table 61. Major Depressive Disorder Drug Customer List
Table 62. Global Major Depressive Disorder Drug SalesForecast by Region (2026-2031) & (K Pcs)
Table 63. Global Major Depressive Disorder Drug RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Americas Major Depressive Disorder Drug SalesForecast by Country (2026-2031) & (K Pcs)
Table 65. Americas Major Depressive Disorder Drug Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. APAC Major Depressive Disorder Drug SalesForecast by Region (2026-2031) & (K Pcs)
Table 67. APAC Major Depressive Disorder Drug Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 68. Europe Major Depressive Disorder Drug SalesForecast by Country (2026-2031) & (K Pcs)
Table 69. Europe Major Depressive Disorder Drug RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Major Depressive Disorder Drug SalesForecast by Country (2026-2031) & (K Pcs)
Table 71. Middle East & Africa Major Depressive Disorder Drug RevenueForecast by Country (2026-2031) & ($ millions)
Table 72. Global Major Depressive Disorder Drug SalesForecast byType (2026-2031) & (K Pcs)
Table 73. Global Major Depressive Disorder Drug RevenueForecast byType (2026-2031) & ($ millions)
Table 74. Global Major Depressive Disorder Drug SalesForecast by Application (2026-2031) & (K Pcs)
Table 75. Global Major Depressive Disorder Drug RevenueForecast by Application (2026-2031) & ($ millions)
Table 76. Bristol-Myers Squibb Company Basic Information, Major Depressive Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 77. Bristol-Myers Squibb Company Major Depressive Disorder Drug Product Portfolios and Specifications
Table 78. Bristol-Myers Squibb Company Major Depressive Disorder Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 79. Bristol-Myers Squibb Company Main Business
Table 80. Bristol-Myers Squibb Company Latest Developments
Table 81. Cerecor Inc. Basic Information, Major Depressive Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. Cerecor Inc. Major Depressive Disorder Drug Product Portfolios and Specifications
Table 83. Cerecor Inc. Major Depressive Disorder Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 84. Cerecor Inc. Main Business
Table 85. Cerecor Inc. Latest Developments
Table 86. e-Therapeutics Plc Basic Information, Major Depressive Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. e-Therapeutics Plc Major Depressive Disorder Drug Product Portfolios and Specifications
Table 88. e-Therapeutics Plc Major Depressive Disorder Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 89. e-Therapeutics Plc Main Business
Table 90. e-Therapeutics Plc Latest Developments
Table 91. Eli Lilly and Company Basic Information, Major Depressive Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. Eli Lilly and Company Major Depressive Disorder Drug Product Portfolios and Specifications
Table 93. Eli Lilly and Company Major Depressive Disorder Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 94. Eli Lilly and Company Main Business
Table 95. Eli Lilly and Company Latest Developments
Table 96.F. Hoffmann-La Roche Ltd. Basic Information, Major Depressive Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 97.F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Product Portfolios and Specifications
Table 98.F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 99.F. Hoffmann-La Roche Ltd. Main Business
Table 100.F. Hoffmann-La Roche Ltd. Latest Developments
Table 101. GlaxoSmithKline Plc Basic Information, Major Depressive Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. GlaxoSmithKline Plc Major Depressive Disorder Drug Product Portfolios and Specifications
Table 103. GlaxoSmithKline Plc Major Depressive Disorder Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 104. GlaxoSmithKline Plc Main Business
Table 105. GlaxoSmithKline Plc Latest Developments
Table 106. H. Lundbeck A/S Basic Information, Major Depressive Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. H. Lundbeck A/S Major Depressive Disorder Drug Product Portfolios and Specifications
Table 108. H. Lundbeck A/S Major Depressive Disorder Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 109. H. Lundbeck A/S Main Business
Table 110. H. Lundbeck A/S Latest Developments
Table 111. Hua Medicine Ltd. Basic Information, Major Depressive Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Hua Medicine Ltd. Major Depressive Disorder Drug Product Portfolios and Specifications
Table 113. Hua Medicine Ltd. Major Depressive Disorder Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 114. Hua Medicine Ltd. Main Business
Table 115. Hua Medicine Ltd. Latest Developments
Table 116. Intra-CellularTherapies, Inc. Basic Information, Major Depressive Disorder Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Intra-CellularTherapies, Inc. Major Depressive Disorder Drug Product Portfolios and Specifications
Table 118. Intra-CellularTherapies, Inc. Major Depressive Disorder Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 119. Intra-CellularTherapies, Inc. Main Business
Table 120. Intra-CellularTherapies, Inc. Latest Developments
LIST OFFIGURES
Figure 1. Picture of Major Depressive Disorder Drug
Figure 2. Major Depressive Disorder Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Major Depressive Disorder Drug Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Major Depressive Disorder Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Major Depressive Disorder Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Major Depressive Disorder Drug Sales Market Share by Country/Region (2024)
Figure 10. Major Depressive Disorder Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Aripiprazole
Figure 12. Product Picture of AV-101
Figure 13. Product Picture of AVP-786
Figure 14. Product Picture of Basimglurant
Figure 15. Product Picture of Brexpiprazole
Figure 16. Product Picture of Others
Figure 17. Global Major Depressive Disorder Drug Sales Market Share byType in 2025
Figure 18. Global Major Depressive Disorder Drug Revenue Market Share byType (2020-2025)
Figure 19. Major Depressive Disorder Drug Consumed in Hospital
Figure 20. Global Major Depressive Disorder Drug Market: Hospital (2020-2025) & (K Pcs)
Figure 21. Major Depressive Disorder Drug Consumed in Clinic
Figure 22. Global Major Depressive Disorder Drug Market: Clinic (2020-2025) & (K Pcs)
Figure 23. Major Depressive Disorder Drug Consumed in Research Center
Figure 24. Global Major Depressive Disorder Drug Market: Research Center (2020-2025) & (K Pcs)
Figure 25. Global Major Depressive Disorder Drug Sale Market Share by Application (2024)
Figure 26. Global Major Depressive Disorder Drug Revenue Market Share by Application in 2025
Figure 27. Major Depressive Disorder Drug Sales by Company in 2025 (K Pcs)
Figure 28. Global Major Depressive Disorder Drug Sales Market Share by Company in 2025
Figure 29. Major Depressive Disorder Drug Revenue by Company in 2025 ($ millions)
Figure 30. Global Major Depressive Disorder Drug Revenue Market Share by Company in 2025
Figure 31. Global Major Depressive Disorder Drug Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Major Depressive Disorder Drug Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Major Depressive Disorder Drug Sales 2020-2025 (K Pcs)
Figure 34. Americas Major Depressive Disorder Drug Revenue 2020-2025 ($ millions)
Figure 35. APAC Major Depressive Disorder Drug Sales 2020-2025 (K Pcs)
Figure 36. APAC Major Depressive Disorder Drug Revenue 2020-2025 ($ millions)
Figure 37. Europe Major Depressive Disorder Drug Sales 2020-2025 (K Pcs)
Figure 38. Europe Major Depressive Disorder Drug Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Major Depressive Disorder Drug Sales 2020-2025 (K Pcs)
Figure 40. Middle East & Africa Major Depressive Disorder Drug Revenue 2020-2025 ($ millions)
Figure 41. Americas Major Depressive Disorder Drug Sales Market Share by Country in 2025
Figure 42. Americas Major Depressive Disorder Drug Revenue Market Share by Country (2020-2025)
Figure 43. Americas Major Depressive Disorder Drug Sales Market Share byType (2020-2025)
Figure 44. Americas Major Depressive Disorder Drug Sales Market Share by Application (2020-2025)
Figure 45. United States Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Major Depressive Disorder Drug Sales Market Share by Region in 2025
Figure 50. APAC Major Depressive Disorder Drug Revenue Market Share by Region (2020-2025)
Figure 51. APAC Major Depressive Disorder Drug Sales Market Share byType (2020-2025)
Figure 52. APAC Major Depressive Disorder Drug Sales Market Share by Application (2020-2025)
Figure 53. China Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. India Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 59. ChinaTaiwan Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Major Depressive Disorder Drug Sales Market Share by Country in 2025
Figure 61. Europe Major Depressive Disorder Drug Revenue Market Share by Country (2020-2025)
Figure 62. Europe Major Depressive Disorder Drug Sales Market Share byType (2020-2025)
Figure 63. Europe Major Depressive Disorder Drug Sales Market Share by Application (2020-2025)
Figure 64. Germany Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 65.France Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Major Depressive Disorder Drug Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Major Depressive Disorder Drug Sales Market Share byType (2020-2025)
Figure 71. Middle East & Africa Major Depressive Disorder Drug Sales Market Share by Application (2020-2025)
Figure 72. Egypt Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 75.Turkey Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Major Depressive Disorder Drug Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Major Depressive Disorder Drug in 2025
Figure 78. Manufacturing Process Analysis of Major Depressive Disorder Drug
Figure 79. Industry Chain Structure of Major Depressive Disorder Drug
Figure 80. Channels of Distribution
Figure 81. Global Major Depressive Disorder Drug Sales MarketForecast by Region (2026-2031)
Figure 82. Global Major Depressive Disorder Drug Revenue Market ShareForecast by Region (2026-2031)
Figure 83. Global Major Depressive Disorder Drug Sales Market ShareForecast byType (2026-2031)
Figure 84. Global Major Depressive Disorder Drug Revenue Market ShareForecast byType (2026-2031)
Figure 85. Global Major Depressive Disorder Drug Sales Market ShareForecast by Application (2026-2031)
Figure 86. Global Major Depressive Disorder Drug Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Chargeable Flexible Battery Market Growth 2025-2031
US$ 3,660.00
January 2025
85 pages
Global Repairs and Maintenance Service for Road and Bridge Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
100 pages
Global Wireless Antenna Market Growth 2025-2031
US$ 3,660.00
December 2024
147 pages
Global Incident Forensics Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
113 pages
Global Mannequin-Based Simulation System Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
100 pages
